Latest Strategy News

Tinybeans Group has completed a partially underwritten entitlement offer, raising $1.7 million to support growth and working capital, with plans to place the remaining shortfall soon.

Resources & Energy Group Limited has raised $2 million to fund drilling and production expansion at its East Menzies Gold Project, following a year of significant operational milestones.

Buru Energy has issued over 55 million attaching options to shareholders who participated in its recent share purchase plan, marking a significant step in its capital raising efforts.

Sierra Nevada Gold (ASX – SNX) has won the rights to explore the expansive As Safra copper-gold project in Saudi Arabia, marking a strategic expansion into a high-potential mining district aligned with the Kingdom’s Vision 2030 ambitions.

Australian Gold and Copper Ltd (AGC) has released an amended initial Mineral Resource Estimate for its Achilles deposit, reporting 38.5 million ounces silver-equivalent and confirming the deposit’s potential as a significant new mineral district in New South Wales.

EV Resources reports exceptional antimony recovery at its Los Lirios project using a simplified gravity process, paving the way for a lower-cost, accelerated development timeline.

Gibb River Diamonds has begun trucking and processing operations at its Neta Gold Mine, securing 130,000 tonnes of ore for milling at two contracted facilities in Western Australia.

CONNEQT Health’s Pulse arterial health monitor sales have outpaced expectations with over 200% growth in the December quarter, driven by efficient marketing and early subscription uptake.

Koonenberry Gold has intersected visible gold in deep drill holes at its Enmore Gold Project, extending the known alteration zone and confirming a robust mineral system open at depth. The company is well funded and advancing a comprehensive drilling program to unlock further potential.

Aureka Limited has raised $3.6 million through a share placement to fund a second diamond drill rig and accelerate exploration at its Victorian gold projects, reflecting strong investor confidence following recent high-grade discoveries.

Recce Pharmaceuticals has won a significant Australian Government R&D tax incentive, unlocking up to A$85 million for its synthetic anti-infective programs worldwide, including a pivotal Phase 3 clinical trial.

HITIQ Limited has successfully completed the initial tranche of a $900,000 placement, issuing over 40 million shares with attached options, while director participation awaits shareholder approval.